Atlas Trials

Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma

Clinical trial NCT02410863 · TERMINATED

Trial details

NCT number
NCT02410863
Sponsor
Prof. Dr. med. Dirk Schadendorf
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2015-11-01
Primary completion
2018-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.